This page shows the latest Hemophilia news and features for those working in and with pharma, biotech and healthcare.
Roche has extended its commitment to the World Federation of Hemophilia (WFH) Humanitarian Aid Program until the end of 2028.
inhibitors. Fitusiran, which Alnylam is co-developing with Sanofi, is in phase 3 trials for hemophilia A and B patients with or without inhibitors, and is expected to arrive on the
Encouraging results for firms in four-way race
Doubts remain on longer term efficacy
Exit also frees up $700m equity investment
Expanded use would see revenues take off
More from news
Approximately 6 fully matching, plus 5 partially matching documents found.
Over the past year Hyne has contributed to conferences and meetings including the World Federation of Hemophilia (WFH) congress and the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee
As we head into 2017, we are fully focused on achieving several important catalysts, including rapidly progressing our hemophilia B programme into late-stage development and advancing our gene therapy candidates
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
2018 has been a tremendous year for Amanda. She has made excellent contributions to many conferences and meetings, including the World Federation of Hemophilia (WFH) congress and the International Society on
In honour of World Hemophilia Day, we are considering the importance of sharing knowledge. ... Haemophilia 2013; 19 (4): 487–498. 8. WFH guidelines for the management of hemophilia.
On World Hemophilia Day, Porterhouse Medical explores changing attitudes towards exercising with the disease and share guides that help people with haemophilia stay active.
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...